未来2到3年内,行业利润向优势药品企业集中的趋势将越来越明显我国医药行业近年来热点不断:反商业贿赂、“齐二药”假药事件、“欣弗”事件、政府推出整顿药价8条意见、国家发改委连续二十多次大幅降低药品价格等等。受访者认为,种种迹象表明,我国医药行业 In the next two to three years, the trend of concentration of industry profits in superior pharmaceutical companies will become more and more obvious. In recent years, the pharmaceutical industry in China has been hot-headed: anti-commercial bribery, “Qi Er Yi” counterfeit drug incident, “Xin Fu” incident and the government’s reorganization Eight drug prices, the National Development and Reform Commission drastic reduction in drug prices more than twenty times and so on. Respondents believe that there are indications that China’s pharmaceutical industry